1. Antibiotic resistance threats in the United States, 2019,2019
2. European Medicine Agency. The bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2009/11/WC500008770.pdf.
3. Appropriate empirical antibacterial therapy for nosocomial infections. Getting it right for the first time;Kollef;Drugs,2003
4. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections;King;Ann Intern Med,2006
5. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials;Deresinski;Diagn Microbiol Infect Dis,2008